Co-expression effect of LLGL2 and SLC7A5 to predict prognosis in ERα-positive breast cancer

MLA

Tomoka Hisada, et al. “Co-Expression Effect of LLGL2 and SLC7A5 to Predict Prognosis in ERα-Positive Breast Cancer.” Scientific Reports, vol. 12, no. 1, Oct. 2022, pp. 1–13. EBSCOhost, https://doi.org/10.1038/s41598-022-20225-4.

APA

Tomoka Hisada, Naoto Kondo, Yumi Wanifuchi-Endo, Satoshi Osaga, Takashi Fujita, Tomoko Asano, Yasuaki Uemoto, Sayaka Nishikawa, Yusuke Katagiri, Mitsuo Terada, Akiko Kato, Hiroshi Sugiura, Katsuhiro Okuda, Hiroyuki Kato, Masayuki Komura, Satoshi Morita, Satoru Takahashi, & Tatsuya Toyama. (2022). Co-expression effect of LLGL2 and SLC7A5 to predict prognosis in ERα-positive breast cancer. Scientific Reports, 12(1), 1–13. https://doi.org/10.1038/s41598-022-20225-4

Chicago

Tomoka Hisada, Naoto Kondo, Yumi Wanifuchi-Endo, Satoshi Osaga, Takashi Fujita, Tomoko Asano, Yasuaki Uemoto, et al. 2022. “Co-Expression Effect of LLGL2 and SLC7A5 to Predict Prognosis in ERα-Positive Breast Cancer.” Scientific Reports 12 (1): 1–13. doi:10.1038/s41598-022-20225-4.